Indo Borax Corrects CSR Committee Composition in Board Meeting Revision
Indo Borax & Chemicals Limited issued a revision correcting the Corporate Social Responsibility Committee composition from its April 06, 2026 board meeting outcome. The corrected committee is chaired by Mr. Suresh Kalra with members Mr. Sunil Malhotra, Ms. Prajnaparamita Sarkar, and Mr. Harsh Malhotra. The original board meeting had approved ESOP 2026 implementation covering 16,88,950 options, policy adoptions for SEBI compliance, and shareholder approval processes.

*this image is generated using AI for illustrative purposes only.
Indo Borax & Chemicals Limited issued a revision to its Board of Directors meeting outcome on April 07, 2026, correcting an inadvertent error in the Corporate Social Responsibility Committee composition disclosed in the original April 06, 2026 board meeting announcement. The company clarified that the error was purely clerical in nature, with no changes to other matters disclosed in the original outcome.
Original Board Meeting Outcomes
The Board of Directors held a comprehensive meeting on April 06, 2026, from 11:30 a.m. to 12:55 p.m., approving several key corporate governance and employee benefit initiatives. The meeting addressed strategic matters including employee stock options, policy adoptions, and committee restructuring in compliance with regulatory requirements.
ESOP 2026 Implementation Approved
The board approved the introduction and implementation of the Indo Borax & Chemicals Limited Employee Stock Option Plan – ESOP 2026, based on recommendations from the Nomination and Remuneration Committee. The scheme aligns with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and requires shareholder approval for final implementation.
| Parameter: | Details |
|---|---|
| Total Options: | 16,88,950 options |
| Convertible Shares: | 16,88,950 equity shares |
| Face Value: | Re. 1/- per share |
| Vesting Period: | 1-5 years from grant date |
| Exercise Period: | 5 years from vesting date |
The ESOP 2026 objectives include rewarding employee performance, sharing company-created wealth with eligible employees, and motivating continuous contribution to growth and profitability.
Pricing and Exercise Framework
The options will be granted at an exercise price determined by the Nomination and Remuneration Committee, with specific parameters ensuring regulatory compliance. Key pricing guidelines include exercise price not less than face value of equity shares, exercise price not exceeding Fair Market Value on grant date, and compliance with accounting policies under SBEB Regulations.
Policy Adoptions and Compliance Updates
The board adopted comprehensive policies ensuring compliance with SEBI regulations and listing requirements. The adopted policies include Code of practices and procedures for fair disclosure of Unpublished Price Sensitive Information (UPSI), Code of conduct for regulating, monitoring, and reporting trading under SEBI (Prohibition of Insider Trading) Regulations, 2015, and Code of fair disclosure practices and policy on determination of legitimate purpose.
Corrected CSR Committee Composition
The company issued a revision on April 07, 2026, correcting the Corporate Social Responsibility Committee composition that was incorrectly mentioned in the original board meeting outcome. The corrected composition reflects the accurate leadership structure for enhanced CSR oversight and implementation.
| Position: | Member Name |
|---|---|
| Chairman: | Mr. Suresh Kalra |
| Member: | Mr. Sunil Malhotra |
| Member: | Ms. Prajnaparamita Sarkar |
| Member: | Mr. Harsh Malhotra |
Shareholder Approval Process
The board approved the draft Postal Ballot Notice for seeking shareholders' approval on proposed resolutions. The notice will be submitted to stock exchanges and dispatched to shareholders following due process, ensuring proper shareholder consultation on significant corporate decisions, particularly the ESOP 2026 implementation.
The meeting outcomes reflect Indo Borax & Chemicals Limited's strategic focus on employee engagement, regulatory compliance, and structured corporate governance while maintaining transparency and regulatory adherence.
Historical Stock Returns for Indo Borax & Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.01% | +4.50% | +3.31% | +5.85% | +50.41% | +71.77% |
What impact will the 16.89 lakh ESOP allocation have on Indo Borax's earnings per share dilution over the next 5 years?
How might the new insider trading and UPSI disclosure policies affect Indo Borax's information flow to analysts and institutional investors?
What specific CSR initiatives is Indo Borax likely to prioritize under the restructured committee leadership?


































